Is there a correlation between venlafaxine therapy during pregnancy and a higher incidence of necrotizing enterocolitis?

World Journal of Pediatrics

Volumn 5, Issue 1, 2009, Pages 65-67

  Treichel, Markus ^a,b   Schwendener Scholl, Katharina ^a   Kessler, Ulf ^a   Joeris, Alexander ^a   Nelle, Mathias ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Antidepressive agents; Necrotizing enterocolitis; Nonselective serotonin reuptake inhibitor; Pregnancy; Venlafaxine

Indexed keywords

AMIKACIN; AMOXICILLIN; OXYGEN; VENLAFAXINE;

ABDOMINAL DISTENSION; ABDOMINAL RADIOGRAPHY; APGAR SCORE; ARTICLE; BIRTH WEIGHT; CASE REPORT; CESAREAN SECTION; COLON ANASTOMOSIS; COLON RESECTION; COLON STENOSIS; CORRELATIONAL STUDY; DEPRESSION; FEMALE; FOOD INTAKE; GESTATIONAL AGE; HEMATOCHEZIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; LABORATORY TEST; LAPAROTOMY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; PNEUMATOSIS INTESTINALIS; PNEUMOPERITONEUM; PREMATURITY; RESPIRATORY FAILURE; SINGLE DRUG DOSE; STOMA; TWINS; VAGINA BLEEDING;

COLECTOMY; COLON; CYCLOHEXANOLS; DEPRESSION; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; ILEUM; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; SEROTONIN UPTAKE INHIBITORS; TWINS;

EID: 59349107059     PISSN: 17088569     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12519-009-0013-6     Document Type: Article

References (12)

1. Product information. Effexor® (venlafaxine hydrochloride) Tablets. Wyeth Pharmaceuticals Inc., 2008. www.wyeth.com/content/ showlabeling.asp?id=99 (accessed July, 2008).
2. Einarson A, Fatoye B, Sarkar M, Lavigne SV, Brochu J, Chambers C, et al. Pregnancy outcome following gestational exposure to venlafaxine: A multicenter prospective controlled study. Am J Psychiatry 2001;158:1728-1730.
3. Costei AM, Kozer E, Ho T, Ito S, Koren G. Perinatal outcomes following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002;156:1129-1132.
4. De Moor RA, Mourad L, ter Haar J, Egberts AC. Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy. Ned Tijdschr Geneeskd 2003;147:1370-1372.
5. Melien O, Skaali T, Myhr K, Brors O. Venlafaxine and asthma. Nord J Psychiatry 2005;59:538-540.
6. Turner RC, Nelson JE, Roberts BT, Gillam DM. Venlafaxine associated interstitial penumonitis. Pharmacotherapy 2005;25:626-629.
7. Stiskal JA, Kulin N, Koren G, Ho T, Ito S. Neonatal paroxetine withdrawal syndrome. Arch Dis Child Fetal Neonatal Ed 2001;84:F134-135.
8. Nair GV, Gurbel PA, O'Connor CM, Gattis WA, Murugesan SR, Serebruany VL. Depression, coronary events, platelet inhibition and serotonin reuptake inhibitors. Am J Cardiol 1999;84:321-323.
9. Muguruma K, Gray PW, Tjoelker LW, Johnston JM. The central role of PAF in necrotizing enterocolitis development. Adv Exp Med Biol 1997;407:379-382.
10. Heier LA, Carpanzano CR, Mast J, Brill PW, Winchester P, Deck MD. Maternal cocaine abuse: The spectrum of radiologic abnormalities in the neonatal CNS. AJNR Am J Neuroradiol 1991;12:951-956.
11. Lopez SL, Taeusch HW, Findlay RD, Walther FJ. Time of onset of necrotizing enterocolitis in newborn infants with known prenatal cocaine exposure. Clin Pediatr (Phila) 1995;34:424-428.
12. Czyrko C, Del Pin CA, O'Neill JA Jr, Peckham GJ, Ross AJ 3rd. Maternal cocaine abuse and necrotizing enterocolitis: Outcome and survival. J Pediatr Surg 1991;26:414-418.